Cranswick, a U.K.-based poultry and pork producer, acquired the entire issued share capital of JSR Genetics Limited from JSR ...

Mallards over the 30 percent farm-raised DNA threshold are showing poor migration habits The author's drake mallard and three ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

The stock market extended its winning streak on Wednesday, closing firmer as investors seemed to have already priced in the ...

Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines.

A large study analyzing over 1.1 million pregnancies found no strong evidence that maternal health conditions during ...

In a recent study, Mass General Brigham researchers demonstrated that through low-cost genetic samples, that can be obtained from a cheek swab or blood test, they can improve identification of people ...

In a retrospective study of 265 patients with drug-resistant solid organ cancers, ‘Exacta AI’ provided at least seven therapy ...

The new Kids First datasets advance our understanding of how genetics contribute to childhood cancers and congenital disorders, opening new doors for prevention and treatment.

When it comes to hair loss, there are as many myths about it as there are treatments for it. An expert broke down common ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...